Skip to main content
. 2022 Oct 7;15:1413–1428. doi: 10.2147/JAA.S382978

Table 3.

Recent Investigations into the Use of Probiotics for Allergic Rhinitis

Author and Date Type of Study Probiotic Type Dosage and Time of Exposure Main Findings Possible Mechanisms Quality of Life and Symptoms, and so on
Xu et al 201659 Randomized, double-blind, placebo-controlled crossover study with 15 adults Clostridium butyricum (Cb) Unclear dose for 7 months IgE, B cells↓
Th2 cells↓
Treg, IL10↑
Inhibition of Th2 immune response Add-on probiotic therapy enhanced SCIT in patients with AR
Jerzynska et al 201661 Prospective and double-blind, randomized, placebo-controlled with 100 children L. rhamnosus GG 1000 IU daily for 5 months IL1, IL6↓
IL10, IL12, TGFβ↑ Th1 cells↑
CD4+CD25+Foxp3+↑
Enhance immune response Add-on probiotic therapy enhanced SLIT in children with AR
Del et al 201752 Randomized, double-blind, placebo-controlled study with 40 children B. longum BB536, B. infantis M-63, B. breve M-16V B. longum BB536 (3x109 CFU), B. infantis M-63 (1x109 CFU), and B. breve M-16 V (1x109 CFU) daily for 8 weeks ## ## Improved AR symptoms and QoL
Berings et al 201755 Randomized, double-blind, placebo-controlled crossover study with 20 adults B. subtilis, B. amyloliquefaciens, B. pumilus strains Bedding for house Purotex® covers 8 weeks ## ## Improved AR symptoms and QoL
Qiao et al 201757 Double-blind, placebo-controlled with 40 adults Clostridium butyricum duplex viable 3 capsules/time Twice a day for 6 weeks IL10, TGFβ↑ Inhibition of Th2 immune response Improved AR symptoms and VAS, RQLQ
Juan et al 201766 Randomized, double-blind, placebo-controlled study with 40 BALB/c mice Clostridium butyricum CGMCC0313-1 1×108 CFU daily for 2 weeks IL4, IL5, IL13, IL17↓ IgE/G1↓ IL10↑ CD4+CD25+Foxp3+↑ Th1/Th2 Cytokine balance Alleviates inflammation
Harata et al 2017121 Double-blind, randomized, placebo-controlled study with 25 pollinosis patients Lactobacillus rhamnosus GG Lactobacillus gasseri TMC0356 110g fermented milk daily for 10 weeks Restore intestinal microbiota balance Regulating blood lipids Alleviates inflammation
Choi et al 201865 Randomized, double-blind, placebo-controlled study with 35 BALB/c mice Lactobacillus plantarum CJLP133 and CJLP243 1×1010 CFU daily for 17 days IL4, IL5, IL13↓
IgE, IgG1↓
IgG2a, IFNγ↑
Th1 cells↑
Th1/Th2 Cytokine balance Reduce inflammation and symptoms
Ren et al 201872 Randomized, double-blind, placebo-controlled study with # #BALB/c mice Bifidobacterium breve Unclear dose for 4 weeks IL4, IL10↓ IgE↓
CD4+CD25+Tregs↑
Inhibition of Th2 immune response Improved AR symptoms
Ahmed et al 201950 Randomized controlled study with 212 children L. paracasei LP33 2x109 CFU daily for 6 weeks IgE↓ Promote Th1 immunity and inhibit Th2 response As effective as cetirizine for perennial AR
Jalali et al 201958 Randomized, double-blind, placebo-controlled crossover study with 152 adults L. acidophilus, L. casei, L. delbrueckii subsp. L. bulgaricus, and L. rhamnosus 11.5×1010 CFU daily for 8 weeks ## ## Add-on probiotic therapy was more effective than budesonide
Meng et al 201962 Randomized, placebo-controlled study with 60 patients Broncho-vaxom (BV) 7mg daily for 10 days, resting 20 days, 3 courses IL4, IL13↓
eosinophils↓
IFNγ↑
Th1/Th2 Cytokine balance Improved TNSS and INSS score
Makino et al 201968 Randomized, double-blind, placebo-controlled study with ## Ovalbumin (OVA)-specific TCR-transgenic DO11.10 mice L. helveticus SBT2171 Unclear dose for 6 weeks IL4, IL13↓
Leukocyte infiltration↓
IL10, IFNγ↑ Th1 cells↑
Th1/Th2 Cytokine balance Alleviates allergic symptoms
Schaefer et al 2019122 Randomized, double-blind, placebo-controlled crossover study with 120 patients Enterococcus faecalis 30 drops each time, 3 times daily for 8 weeks Restore intestinal microbiota balance Regulate immune response Improved AR symptoms
Kim et al 2019123 Randomized, double-blind, placebo-controlled crossover study with 48 BALB/c mice Bifidobacterium longum IM55 and Lactobacillus plantarum IM76 2×109 CFU daily for 30 days IL4, IL5↓
Th2 cells, Mast cells ↓ eosinophils, basophils↓ Bacteroides↓ Proteobacteria↑ Actinomycetes↑
Restoring Th2/Treg imbalance and gut microbiota disturbance Improved AR symptoms
Yamashita et al 202051 Randomized, double-blind, placebo-controlled study with 200 adults L. helveticus SBT2171 10g daily for 12 weeks IgE↓
eosinophils↓
Th1/Th2 Cytokine balance or Inhibition of Th2 immune response Improved AR symptoms
Kang et al 202053 Multi-center, double-blind, randomized, placebo-controlled with 97 adults B. longum IM55, L. plantarum IM76 1×1010 CFU daily for 4 weeks IL4, IL5, IL13↓ PDG2↓
Cysteine LTs↓ IgE↓
Mast cells↓ B cells↓ eosinophils↓ Th2 cells↓ Treg↑ IL10↑
Th1/Th2 Cytokine balance Improved TNSS and RCAT score
Anania et al 202154 Prospective and double-blind, randomized, placebo-controlled with 250 children Lactis BB12, Enterococcus faecium L3 4×1010 CFU daily for 3 months ## ## Improved NSS score
Bae et al 202167 Randomized, double-blind, placebo-controlled crossover study with # #BALB/c mice Fermented by probiotic bacteria (FRG) Unclear dose for more than 2 weeks IL4, eosinophils↓
basophils, IgE↓
Inhibition of Th2 immune response Alleviates inflammation
Hu et al 2021124 Randomized, double-blind, placebo-controlled crossover study with 130 children Lactobacillus reuteri GL-104, Lactobacillus paracasei GL-156, Lactobacillus rhamnosus MP-108 500mg each time, 3 times daily for 12 weeks Restore intestinal microbiota balance Restore intestinal barrier function Alleviates inflammation
Yang et al 202271 Randomized, double-blind, placebo-controlled crossover study with # #BALB/c mice Lactiplantibacillus plantarum NR16 Unclear time and dose IL12, IFNγ↑ Induce Th1 immune response and balance Th2/Th1 ratio Improved AR symptoms

Abbreviations: AR, allergic rhinitis; QoL, quality of life; RCAT, rhinitis control assessment test; SCIT, subcutaneous immunotherapy; SLIT, sublingual immunotherapy; NSS, nasal symptom score; INSS, individual nasal symptom score; TNSS, total nasal symptom score; VAS, visual analogue score; RQLQ, rhinoconjunctivitis quality of life scale; ##, not mentioned or not applicable.